Skip to content

Effect of Elliptical Training on Metabolic Homeostasis in Metabolic Syndrome

Effect of Elliptical Training on Lipids, Glucose and Insulin Homeostasis in Metabolic Syndrome

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04635202
Enrollment
60
Registered
2020-11-19
Start date
2020-09-09
Completion date
2021-06-01
Last updated
2020-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome

Brief summary

The growing prevalence of metabolic syndrome (MetS) in the worldwide is becoming a serious health problem and economic burden. MetS has become a crucial risk factor for the development of type 2 diabetes mellitus (T2DM) and cardiovascular diseases (CVD). The rising rates of CVD and diabetes, which are the two leading causes of death. To prevent the progression of MetS to diabetes and CVD, regular physical activity is required. Elliptical trainer device is a relatively new modality of exercise and is advertised to be superior to a treadmill because of the low joint impact and the more reasonable costs of an elliptical trainer compared to a treadmill. Additional quantitative research is needed to further evaluate the effectiveness of elliptical trainers and the physiological and perceptual responses to the machine.

Detailed description

Forty sedentary MeTS patients (from both sexes) will be randomly divided to group A and group B. -Group A (Elliptical training group): This group (n=20) will receive aerobic training on an elliptical trainer for 16 weeks (3 sessions per week). The session will start with 5 minutes warming up at 50 % of maximal heart rate (MHR), 20-minute continuous ET at 70% of MHR, 12 minutes (4×3) intervals at 90% of MHR with a 3-minute active recovery at 70% of MHR between intervals, and finally 5-minute cool-down period at 50% of MHR. Group B: this group will continue their normal daily physical activities without any additional training

Interventions

BEHAVIORALexercise training on elliptical device

This group (n=30) will receive aerobic training on an elliptical trainer for 16 weeks (3 sessions per week). The session will start with 5 minutes warming up at 50 % of maximal heart rate (MHR), 20-minute continuous ET at 70% of MHR, 12 minutes (4×3) intervals at 90% of MHR with a 3-minute active recovery at 70% of MHR between intervals, and finally 5-minute cool-down period at 50% of MHR

this group will receive general advises on maintaining physical activities for 16 weeks without any additional supervised training

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
30 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* The MeTS subjects who will have three or more of the following criteria: 1) waist circumference more than 102 cm, triglycerides more than 150 mg/dL, 3) blood pressure (BP) more than 130/85 mmHg, 4) high-density lipoprotein (HDL) less than 40 mg/dL, .

Exclusion criteria

* Renal, pulmonary, cardiac, vascular, respiratory, hepatic, autoimmune disorders. * Smoker, addictive, cancer, and alcoholic patients. * Lower limb arthritis or any orthopaedic problem will hinder the training. * Participation in any type of sport training in the previous 6 months. * Pregnant or lactating women. * Patients with thyroid gland dysfunction.

Design outcomes

Primary

MeasureTime frameDescription
TriglyceridesIt will be measured after 16 weeks of trainingTriglycerides is one of lipid profile indicators
high density lipoproteinIt will be measured after 16 weeks of traininghigh density lipoprotein is one of lipid profile indicators

Secondary

MeasureTime frameDescription
Fasting blood glucoseIt will be measured after 16 weeks of trainingIt will be measured via a blood glucose meter
InsulinIt will be measured after 16 weeks of trainingit will be measured via a blood sample
The HOMA-IR (Homeostatic Model Assessment for Insulin ResistanceIt will be measured after 16 weeks of trainingHOMA-IR = \[fasting insulin (μU/mL) × fasting glucose (mmol)\]/22.5
Systolic blood pressureIt will be measured after 16 weeks of trainingIt will be measured via Sphygmomanometer
weightIt will be measured after 16 weeks of trainingthe weight scale will be used
Leg strength testIt will be measured after 16 weeks of trainingwill be assessd by leg dynamometer
% body fatIt will be measured after 16 weeks of trainingpercentage of body fat composition
Waist circumferenceIt will be measured after 16 weeks of trainingit will be measured by inelastic tape at the umbilicus level
diastolic blood pressureIt will be measured after 16 weeks of trainingIt will be measured via Sphygmomanometer

Countries

Egypt

Contacts

Primary ContactAli Ismail, lecturer
allooka2012@gmail.com02 01005154209

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026